Science ❯ Biotechnology ❯ Artificial Intelligence ❯ Protein Engineering
Researchers have created a multi-neoantigen vaccine blueprint alongside de novo protein binders that achieved precise T cell–mediated melanoma cell killing in vitro, now advancing into animal safety studies.
